Haemolytic Anaemias — Intravascular vs Extravascular, Hereditary Spherocytosis, G6PD Deficiency, AIHA, PNH and Sickle Cell Disease

Written & medically reviewed by the Kinase Medical Team · Last reviewed

Quick Answer

Haemolytic anaemia is early destruction of red cells, which normally live 120 days. Labs show raised reticulocytes, LDH and indirect bilirubin with low haptoglobin. Hereditary spherocytosis is Coombs-negative with high MCHC; G6PD deficiency gives bite cells and Heinz bodies after oxidant drugs; warm AIHA is IgG and Coombs-positive; PNH lacks CD55/CD59.

What is haemolytic anaemia and how is it confirmed?

Red cells normally survive about 120 days. Haemolytic anaemia is anaemia from their premature destruction. It can be classified as acute or chronic, inherited or acquired, immune or non-immune, intracorpuscular (defect inside the red cell) or extracorpuscular, and intravascular or extravascular by where the cells are destroyed.

Four tests confirm haemolysis: raised reticulocyte count, raised LDH, raised unconjugated (indirect) bilirubin and low haptoglobin. Haptoglobin falls because it binds the free haemoglobin released from lysed cells and is then cleared. The peripheral smear and the direct antiglobulin (Coombs) test then point to the cause. See anaemia classification and approach for where haemolysis fits in the wider work-up.

Causes of haemolysis by mechanism
GroupExamples
Membrane defects (intrinsic)Hereditary spherocytosis, hereditary elliptocytosis
Enzyme defects (intrinsic)G6PD deficiency, pyruvate kinase deficiency
Haemoglobin defects (intrinsic)Sickle cell disease, thalassaemia
Immune (extrinsic)Warm AIHA, cold agglutinin disease, paroxysmal cold haemoglobinuria
Mechanical / microangiopathic (extrinsic)TTP, HUS, DIC, HELLP, prosthetic valves
Acquired membrane defectParoxysmal nocturnal haemoglobinuria (PNH)
Infection / otherMalaria, Clostridium perfringens sepsis
Haemolytic Anaemia - classification (intravascular, extravascular), pathophysiology, investigationsHand-drawn overview of intravascular vs extravascular haemolysis, causes and laboratory tests.Video: Armando Hasudungan · 13:21 · Watch on YouTube · Loads from YouTube (privacy-enhanced mode) only when you press play.

How does intravascular haemolysis differ from extravascular haemolysis?

Intravascular vs extravascular haemolysis
FeatureIntravascularExtravascular
SiteInside blood vesselsSpleen (and liver) macrophages
MechanismComplement lysis, shear, toxinsRigid or antibody-coated cells trapped and phagocytosed
Free plasma haemoglobinHigh (toxic to vessels, raises thrombosis risk)Little
HaptoglobinLowLow
UrineHaemoglobinuria; haemosiderin deposits in kidneysNo haemoglobinuria
ExamplesPNH, paroxysmal cold haemoglobinuria, cold agglutinin disease, microangiopathic haemolysisHereditary spherocytosis, warm AIHA, sickle cell disease

What are the key features of hereditary spherocytosis?

Hereditary spherocytosis (HS) is the commonest inherited haemolytic anaemia due to a red-cell membrane defect (about 1 in 2,000). Deficiency of a cytoskeletal protein — spectrin (most often), ankyrin, band 3 or band 4.2 — weakens the link between the cytoskeleton and the lipid bilayer. The cell loses membrane, becomes a small sphere, cannot deform and is destroyed in the spleen. Ankyrin mutations cause both dominant and recessive forms.

  • Clinical: anaemia, jaundice, splenomegaly, family history; gallstones (cholelithiasis) are a known complication.
  • Lab clue: Coombs-negative haemolysis with raised MCHC and spherocytes on the smear.
  • Confirmatory tests: eosin-5-maleimide (EMA) binding by flow cytometry (validated by the BCSH guideline), osmotic fragility (increased) and acidified glycerol lysis test.
  • Crises: haemolytic (commonest, triggered by viral infection), aplastic (parvovirus B19 — worse, may cause heart failure) and megaloblastic.
  • Severity by haemoglobin: severe < 8 g/dL, moderate 8–10 g/dL, mild 10–11.5 g/dL (women) or 10–13.5 g/dL (men); clinical response to splenectomy tracks the degree of spectrin deficiency.
  • Treatment: splenectomy improves most patients; afterwards Howell-Jolly bodies appear and lifelong risk of sepsis from encapsulated organisms (S. pneumoniae, N. meningitidis, H. influenzae) needs vaccination.

How does G6PD deficiency cause haemolysis and which drugs trigger it?

G6PD catalyses the first, rate-limiting step of the pentose phosphate pathway, making NADPH. NADPH keeps glutathione reduced so it can detoxify hydrogen peroxide. Red cells have no other source of NADPH, so in G6PD deficiency oxidant stress denatures haemoglobin into Heinz bodies and damages the membrane. The gene is X-linked, so males are mainly affected, though heterozygous females can be affected because of lyonisation. It is common across the malaria belt.

Triggers of haemolysis in G6PD deficiency
TriggerExamples
InfectionsAny acute infection
FoodsFava beans (favism)
AntimalarialsPrimaquine, tafenoquine
AntibacterialsSulfonamides, dapsone, nitrofurantoin (caution)
OthersRasburicase, pegloticase, phenazopyridine; methylene blue is ineffective (it needs NADPH)
  • Smear: bite cells and blister cells; Heinz bodies need a supravital stain.
  • Episodic: haemolysis is acute and self-limited once the trigger is removed; chronic haemolysis is rare.
  • Testing trap: enzyme assay during an attack can be falsely normal — repeat the quantitative assay after recovery.
  • Newborns: G6PD deficiency causes severe neonatal jaundice; in one US registry about 20% of infants with kernicterus had it.

Pyruvate kinase deficiency is the other enzyme defect to know. Red cells depend on glycolysis for energy, so the defect starves them of ATP. Increased 2,3-DPG improves oxygen unloading in the tissues. The smear shows polychromasia with echinocytes; PKLR gene mutations confirm it, and severe cases benefit from splenectomy in late childhood with vaccination against encapsulated bacteria.

How do warm and cold autoimmune haemolytic anaemias differ?

Autoimmune haemolytic anaemias
FeatureWarm AIHACold agglutinin diseaseParoxysmal cold haemoglobinuria
AntibodyIgG (reacts at 37 °C)IgM (reacts in the cold)IgG Donath-Landsteiner (biphasic)
DAT resultIgG ± C3dC3d (IgG negative or weak)C3d
Site of haemolysisExtravascular — spleenIntravascular on rewarmingIntravascular on rewarming, haemoglobinuria
Associations50–60% secondary to an underlying condition; rest idiopathicPrimary or secondary (infection, lymphoproliferative)Confirmed by the Donath-Landsteiner test
First-line treatmentPrednisone 1–2 mg/kg/day (70–85% respond)Rituximab (± bendamustine) if symptomaticSupportive care

The direct antiglobulin test (DAT, direct Coombs) detects antibody or complement already bound to the patient's red cells — the key test for immune haemolysis. The indirect antiglobulin test detects free antibody in the serum that could react with donor red cells, as in cross-matching. About 5–10% of AIHA is DAT-negative, so a negative DAT does not fully exclude it.

Blood smear with many small, dense, round red cells lacking central pallor, larger bluish-tinged red cells, a neutrophil and a nucleated red cell.
Warm autoimmune haemolytic anaemia: spherocytes, polychromatic (young) red cells and a nucleated red cell.Image: Spicy, CC BY-SA 4.0
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)Short comparison of warm AIHA (IgG) and cold agglutinin disease (IgM).Video: Osmosis from Elsevier · 6:33 · Watch on YouTube · Loads from YouTube (privacy-enhanced mode) only when you press play.

What causes paroxysmal nocturnal haemoglobinuria?

PNH is an acquired stem-cell disorder caused by a somatic mutation of the X-linked PIGA gene. Without PIGA the cell cannot make the glycosylphosphatidylinositol (GPI) anchor, so GPI-anchored complement regulators CD55 and CD59 are missing. Red cells are then lysed by complement inside vessels.

  • Triad: intravascular haemolysis (haemoglobinuria), thrombosis and bone-marrow failure (cytopenias; overlaps with aplastic anaemia).
  • Thrombosis — often in unusual sites such as hepatic veins (Budd-Chiari) — is the commonest cause of death.
  • Diagnosis: flow cytometry for absent GPI-anchored proteins, including FLAER — the gold standard.
  • Treatment: complement C5 inhibitors eculizumab and ravulizumab have brought survival close to normal; they raise the risk of meningococcal infection, so vaccinate first.

What are the high-yield facts about sickle cell disease?

Sickle cell disease is autosomal recessive. A point mutation in the beta-globin gene on chromosome 11 replaces glutamate with valine at position 6, forming HbS, which polymerises when deoxygenated and distorts red cells into sickles. Rigid cells block small vessels (vaso-occlusion) and are destroyed early. Sickle cell trait (HbAS) rarely causes symptoms.

  • Diagnosis: haemoglobin electrophoresis, HPLC or isoelectric focusing.
  • Spleen: splenic sequestration in children aged 1–4 years while the spleen is still intact; later loss of splenic function → invasive bacterial infections and Howell-Jolly bodies.
  • Aplastic crisis: parvovirus B19 — haemoglobin drops at least 3–6 g/dL below baseline with low reticulocytes.
  • Stroke: the most devastating complication; without prevention about 10% of children have an overt stroke.
  • Acute chest syndrome: antibiotics (cephalosporin plus macrolide), oxygen, analgesia, transfusion and incentive spirometry.
  • Hydroxyurea: ribonucleotide reductase inhibitor that raises HbF; MCV rises on treatment. Crizanlizumab blocks P-selectin to reduce pain crises.
Blood smear with many elongated, crescent-shaped red cells among round red cells, an arrow marking one curved sickle cell, and a neutrophil in the centre.
Sickle cells (drepanocytes) formed by polymerised haemoglobin S.Image: Paulo Henrique Orlandi Mourao, CC BY-SA 4.0

Which smear findings point to which haemolytic anaemia?

Smear clue → diagnosis
Smear findingThink of
Spherocytes, DAT negativeHereditary spherocytosis
Spherocytes, DAT positiveWarm AIHA
Bite / blister cells, Heinz bodiesG6PD deficiency
Schistocytes (fragments)TTP, HUS, DIC, mechanical valve, HELLP
Sickle cells, Howell-Jolly bodiesSickle cell disease
Target cellsThalassaemia, haemoglobinopathies, liver disease, post-splenectomy
  • Haptoglobin is the most sensitive marker of haemolysis; LDH and bilirubin can also rise with other causes.
  • Normal G6PD level during an acute attack does not exclude deficiency — repeat after recovery.
  • PNH is acquired, not inherited, even though PIGA is on the X chromosome.
  • Cold agglutinin disease is IgM and complement-mediated; paroxysmal cold haemoglobinuria is IgG (Donath-Landsteiner).
  • Aplastic crisis in any chronic haemolytic anaemia (HS, sickle cell) = parvovirus B19, with a low reticulocyte count.

Related: kernicterus and neonatal jaundice for haemolysis in newborns, megaloblastic anaemia and hypersensitivity reactions — AIHA is a classic type II reaction.

Frequently asked questions

What laboratory findings confirm haemolysis?
Haemolysis is supported by a raised reticulocyte count, raised lactate dehydrogenase, raised unconjugated bilirubin and low haptoglobin. Haptoglobin binds free haemoglobin and is cleared, so it falls early and is the most sensitive marker. Intravascular haemolysis also releases free haemoglobin into plasma and urine (haemoglobinuria), whereas in extravascular haemolysis macrophages in the spleen remove the cells.
Which test confirms hereditary spherocytosis?
Hereditary spherocytosis is suggested by Coombs-negative haemolysis, a raised MCHC, spherocytes on the smear and a family history. A specialised test then confirms it: the eosin-5-maleimide (EMA) binding test by flow cytometry, the osmotic fragility test or the acidified glycerol lysis test. The British guideline validates the EMA binding test as a diagnostic tool.
Why are Heinz bodies formed in G6PD deficiency?
G6PD makes NADPH, which keeps glutathione reduced to neutralise hydrogen peroxide. Without it, oxidant stress from infection, fava beans or drugs such as primaquine, dapsone and sulfonamides oxidises haemoglobin, which denatures and clumps into Heinz bodies. These need a supravital stain to see, and splenic removal of them leaves bite cells.
How do warm and cold autoimmune haemolytic anaemias differ?
Warm AIHA is caused mainly by IgG antibodies that react at body temperature; red cells are destroyed in the spleen and corticosteroids are first-line. Cold agglutinin disease is caused by IgM antibodies that bind red cells in the cold and fix complement, so the DAT shows C3d and haemolysis occurs on rewarming. Rituximab is first-line for symptomatic cold disease.
What is the difference between direct and indirect Coombs tests?
The direct antiglobulin test looks for antibody or complement already coating the patient's own red cells and is the key test for autoimmune haemolytic anaemia. The indirect antiglobulin test looks for free antibodies in the patient's serum that could react with other red cells, as in cross-matching before transfusion. About 5 to 10 percent of AIHA is DAT-negative.
What is the molecular defect in paroxysmal nocturnal haemoglobinuria?
PNH results from an acquired somatic mutation of the PIGA gene in a blood stem cell. The cell cannot build the GPI anchor, so complement-regulating proteins CD55 and CD59 are absent from the red-cell surface and complement destroys the cells. Thrombosis is the commonest cause of death, flow cytometry with FLAER confirms the diagnosis and eculizumab treats it.
What causes an aplastic crisis in hereditary spherocytosis or sickle cell disease?
Parvovirus B19 infects red-cell precursors and briefly stops red-cell production. In a patient whose red cells already survive only a short time, this causes a sudden fall in haemoglobin — at least 3 to 6 g/dL below baseline in sickle cell disease — with a low reticulocyte count. It is usually worse than a haemolytic crisis and can cause heart failure.
How does hydroxyurea help in sickle cell disease?
Hydroxyurea inhibits ribonucleotide reductase and raises the concentration of fetal haemoglobin (HbF); an HbF level of 10 to 15 percent already eases symptoms. It also lowers the number of circulating reticulocytes and white cells and raises red-cell volume, so a high MCV is expected on treatment. It benefits patients with frequent, severe complications.

Sources

  1. StatPearls — Hemolytic Anemia (NCBI Bookshelf)
  2. StatPearls — Hereditary Spherocytosis (NCBI Bookshelf)
  3. Bolton-Maggs PH et al. — Guidelines for the diagnosis and management of hereditary spherocytosis, 2011 update (Br J Haematol; PubMed 22055020)
  4. StatPearls — Glucose-6-Phosphate Dehydrogenase Deficiency (NCBI Bookshelf)
  5. StatPearls — Laboratory Evaluation of Immune Hemolytic Anemias (NCBI Bookshelf)
  6. StatPearls — Anemia (NCBI Bookshelf)
  7. StatPearls — Paroxysmal Nocturnal Hemoglobinuria (NCBI Bookshelf)
  8. StatPearls — Sickle Cell Anemia (NCBI Bookshelf)

For exam preparation and education only — not a substitute for clinical judgement or local guidelines. How we write and review these pages: editorial policy.

Revise Haemolytic Anaemias with questions

Kinase: NEET-PG & INICET has previous-year papers, a subject-wise QBank and Grand Tests with explanations — on Android, iOS and the web.